WaveMan · Form 4
Wiggans Thomas G insider trades
> Search tickers & screens ⌘K
LIVE

Wiggans Thomas G insider trades

Wiggans Thomas G has filed 25 Form 4s with the SEC that we hold, for Jasper Therapeutics, Inc. (JSPR) (Director), PRDS (Chief Executive Officer, Director), Annexon, Inc. (ANNX) (Director) and CBAY (Director), among 6 companies in all. Across all of them we count 9 purchases worth $183.8K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 41,000 shares of Jasper Therapeutics, Inc. worth $99.6K, dated 2025-09-22. The first filing on our record is dated 2022-01-27 and the latest 2026-08-04.

Jasper Therapeutics, Inc. (JSPR)

Director · 8 filings · 6 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-11-16P, purchase reported on Form 410,000$6.0K2023-11-20
2023-11-17P, purchase reported on Form 410,000$6.0K2023-11-20
2023-11-20P, purchase reported on Form 410,000$6.3K2023-11-20
2023-11-21P, purchase reported on Form 410,000$6.4K2023-11-22
2023-11-28P, purchase reported on Form 410,000$6.5K2023-11-30
2025-09-22P, purchase reported on Form 441,000$99.6K2025-09-24

PRDS

Chief Executive Officer, Director · 6 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-12-01P, purchase reported on Form 425,000$26.0K2022-12-05
2022-12-02P, purchase reported on Form 412,500$13.4K2022-12-05
2022-12-05P, purchase reported on Form 412,500$13.6K2022-12-07

Annexon, Inc. (ANNX)

Director · 4 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

CBAY

Director · 4 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

FMTX

Director · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Pacira BioSciences, Inc. (PCRX)

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1208907) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms